MDS | Tumor

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

‘General Hospital’ Star Reveals Cancer Diagnosis, Paul Reubens’ Cause of Death Confirmed and More

September 15th 2023, 3:00pm

Article

As The Los Angeles Rams celebrate a cancer survivor and a 9/11 survivor reveals his fourth cancer diagnosis, this is what’s happening in the oncology space this week.

Blood Cancer Approvals from Summer 2023

September 2nd 2023, 3:00pm

Article

Here’s a look back at blood cancer approvals from the summer of 2023.

FDA Approves Reblozyl to Treat Anemia in MDS Subset

August 29th 2023, 11:32am

Article

The Food and Drug Administration approved Reblozyl to treat low red blood cell count in patients with very low- to intermediate-risk myelodysplastic syndrome.

FDA to Speed Up Review of Tibsovo for IDH1-Mutant MDS

August 17th 2023, 1:00pm

Article

The Food and Drug Administration granted a priority review to Tibsovo for the treatment of patients with IDH1-mutant relapsed or refractory myelodysplastic syndrome.

MDS Diagnoses Need an Expert Opinion

August 9th 2023, 3:00pm

Article

Patients with myelodysplastic syndrome should seek an expert opinion on their disease to ensure an accurate diagnosis and proper treatment plan.

Cancer Surprisingly Expanded My Work

August 7th 2023, 9:00pm

Article

I was devastated when I had to stop working due to my cancer diagnosis. However, I eventually found a new line of work that I'm grateful for.

Promacta Improves Platelet Count, Transfusion Independence in MDS

July 24th 2023, 1:00pm

Article

Promacta tended to boost platelet counts in patients with low-risk MDS, and helped those patients be independent of transfusions, too.

Doctors and More Doctors: A Way of Life for Cancer Survivors

July 21st 2023, 5:00pm

Article

The bonds that you make with your doctors can last a lifetime, and I’m so glad to call many of them a friend.

Reblozyl Improves Blood Transfusion Independence in Lower-Risk MDS

July 10th 2023, 7:00pm

Article

Reblozyl treatment in patients with anemia from lower-risk myelodysplastic syndromes achieved a greater independence from red blood cell transfusions compared with treatment with epoetin alfa.

Expanded Access Protocol Makes Imetelstat Available to Patients With MDS

July 4th 2023, 1:00pm

Article

Patients with lower risk myelodysplastic syndrome may now receive imetelstat — despite it not being FDA-approved.